TR201908082T4 - Diyabetin tedavi edilmesi ve vücut ağırlığının azaltılmasına yönelik eksendin. - Google Patents

Diyabetin tedavi edilmesi ve vücut ağırlığının azaltılmasına yönelik eksendin. Download PDF

Info

Publication number
TR201908082T4
TR201908082T4 TR2019/08082T TR201908082T TR201908082T4 TR 201908082 T4 TR201908082 T4 TR 201908082T4 TR 2019/08082 T TR2019/08082 T TR 2019/08082T TR 201908082 T TR201908082 T TR 201908082T TR 201908082 T4 TR201908082 T4 TR 201908082T4
Authority
TR
Turkey
Prior art keywords
body weight
exend
treat diabetes
reduce body
reducing
Prior art date
Application number
TR2019/08082T
Other languages
English (en)
Inventor
Fineman Mark
Macconell Leigh
Taylor Kristin
Original Assignee
Amylin Pharmaceuticals Llc
Astrazeneca Pharmaceuticals Lp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amylin Pharmaceuticals Llc, Astrazeneca Pharmaceuticals Lp filed Critical Amylin Pharmaceuticals Llc
Publication of TR201908082T4 publication Critical patent/TR201908082T4/tr

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Eksendinler, eksendin agonistleri veya eksendin analogu agonistlerinin kullanımı vasıtasıyla vücut ağırlığının azaltılması, vücut bileşiminin değiştirilmesi, diyabetin tedavi edilmesi, HbA 1c'nin azaltılması ve ortalama günlük kan glukozunun azaltılmasına yönelik yöntemler sağlanmaktadır.
TR2019/08082T 2006-03-03 2006-08-18 Diyabetin tedavi edilmesi ve vücut ağırlığının azaltılmasına yönelik eksendin. TR201908082T4 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77921606P 2006-03-03 2006-03-03
US70960406P 2006-03-03 2006-03-03

Publications (1)

Publication Number Publication Date
TR201908082T4 true TR201908082T4 (tr) 2019-06-21

Family

ID=67952742

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/08082T TR201908082T4 (tr) 2006-03-03 2006-08-18 Diyabetin tedavi edilmesi ve vücut ağırlığının azaltılmasına yönelik eksendin.

Country Status (1)

Country Link
TR (1) TR201908082T4 (tr)

Similar Documents

Publication Publication Date Title
MX2008002370A (es) Exendina para tratar la diabetes y reducir el peso del cuerpo.
MX2007010560A (es) Roflumilast para el tratamiento de diabetes mellitus.
IL185808A0 (en) Amide-substituted 8-n-benzimidazoles, metohd for the production thereof, and use of the same as medicaments
EA201000515A1 (ru) Активаторы глюкокиназы
EA201101189A1 (ru) Ингибитор sglt-2, предназначенный для лечения сахарного диабета типа 1, сахарного диабета типа 2, нарушенной толерантности к глюкозе или гипергликемии
ATE539748T1 (de) Glucokinaseaktivatoren
EA200900392A1 (ru) Комбинированное лечение сахарного диабета
HK1122803A1 (tr)
WO2010029089A3 (en) Combination therapy for the treatment of diabetes and related conditions
TW200833330A (en) Substituted dihydropyrazolones and their use
WO2006102374A3 (en) Bioactive wide-weave mesh
KZ24152B (en) Method of photosensitizer activation, treatment method with application of activated photosensitizer and photosensitizer application to prepare medicine
EA201101187A1 (ru) Антидиабетические лекарственные средства, содержащие ингибитор dpp-4 (линаглиптин) необязательно в комбинации с другими антидиабетическими средствами
EP1845105A4 (en) MODIFIED EXENDINES AND CORRESPONDING USES
WO2009026657A8 (en) Flavonoid ppar agonists
WO2004028516A3 (de) Zusammensetzungen zur hemmung der proteinkinase c alpha zur behandlung von diabetes mellitus und kardiovaskulärer erkrankungen
CA2634419C (en) Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
MX2009009416A (es) Derivados de bencimidazol y sus metodos de uso.
EA201100097A1 (ru) Производные пиразоло[3,4]пиримидин-4-ила и их применения для лечения диабета и ожирения
RS52629B (en) LIXISENATIDE AS ADDITIONAL THERAPY INSULIN GLARGINE AND METFORMIN FOR TYPE 2 DIABETES TREATMENT
EP1890708A4 (en) GLUCOSE INDUCIBLE INSULIN EXPRESSION AND METHODS OF TREATING DIABETES
MY182983A (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
MXPA06012206A (es) Composicion farmaceutica ozonizada y metodos.
WO2006138537A3 (en) Ex vivo blood treatment with renal epithelial cells in cardiorenal and hepatorenal syndrome
ATE485832T1 (de) Glucoseisomerase zur behandlung von fructose- unverträglichkeit